Pharmafile Logo
Pharmafocus logo
Advanced Search

merrimack

Showing 4 posts of 4 posts found.

shutterstock_243110086

Merrimack shuts down development of investigational cancer drug, staff cuts to follow

April 8, 2019
Research and Development, Sales and Marketing cacner, merrimack, oncology, pharma

Merrimack Pharmaceuticals has taken the decision to terminate development of its antibody-directed nanotherapeutic cancer therapy MM-310 in the treatment of …

News
handshake-1910702_960_720

Merrimack sells off drug for $1 billion and cuts workforce by 80%

January 9, 2017
Sales and Marketing Onivyde, ipsen, merrimack

Ipsen has announced the agreement to acquire oncology assets from Merrimack Pharmaceuticals, most notably the pancreatic cancer drug Onivyde, in …

News
merrimack-pharmaceuticals

Merrimack’s breast cancer trial stutters to halt

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merrimack Pharmaceuticals, merrimack

Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …

News
sanofi image

Third failure for Sanofi/Merrimack cancer drug

November 27, 2013
Research and Development, Sales and Marketing Cancer, Sanofi, merrimack, mm-121

Sanofi and partner Merrimack have posted yet more disappointing results for their investigational cancer medicine MM-121. In the latest study …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025